arginine has been researched along with amifampridine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hertting, G; Jackisch, R; Lauth, D | 2 |
Birthelmer, A; Cassel, JC; Förstermann, U; Gödtel-Armbrust, U; Jackisch, R; Knörle, R; Lazaris, A; Schweizer, T | 1 |
3 other study(ies) available for arginine and amifampridine
Article | Year |
---|---|
Involvement of nitric oxide synthase in 3,4-diaminopyridine-evoked noradrenaline release in rat hippocampus.
Topics: 4-Aminopyridine; Amifampridine; Amino Acid Oxidoreductases; Animals; Arginine; Electric Stimulation; Hippocampus; In Vitro Techniques; Nitric Oxide Synthase; Norepinephrine; Potassium Channels; Rats; Signal Transduction | 1993 |
3,4-Diaminopyridine-evoked noradrenaline release in rat hippocampal slices: facilitation by endogenous or exogenous nitric oxide.
Topics: 4-Aminopyridine; Amifampridine; Animals; Arginine; Cyclic GMP; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Hemoglobins; Hippocampus; In Vitro Techniques; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Norepinephrine; Perfusion; Rats; Synaptosomes | 1995 |
Cognitive deficits in aged rats correlate with levels of L-arginine, not with nNOS expression or 3,4-DAP-evoked transmitter release in the frontoparietal cortex.
Topics: 4-Aminopyridine; Acetylcholine; Aging; Amifampridine; Animals; Arginine; Cerebral Cortex; Cognition Disorders; Female; Frontal Lobe; Gene Expression Regulation; Nerve Tissue Proteins; Neurotransmitter Agents; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Norepinephrine; Parietal Lobe; Rats; Rats, Long-Evans; Serotonin | 2005 |